Lisa Bright
Child & Adolescent Psychiatry · Juneau, WINPI 1093949760
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,522, more than ten times the $63 reported in 2022. Among child & adolescent psychiatry clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$727
- Lundbeck LLC$653
- Otsuka America Pharmaceutical, Inc.$338
- Alkermes, Inc.$300
- Takeda Pharmaceuticals U.S.A., Inc.$231
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$206
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,482100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 60 | $727 |
| Lundbeck LLC | 43 | $653 |
| Otsuka America Pharmaceutical, Inc. | 24 | $338 |
| Alkermes, Inc. | 15 | $300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $231 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $206 |
| AbbVie | 11 | $172 |
| Corium, LLC | 9 | $143 |
| E.r. Squibb & Sons, L.L.C. | 7 | $141 |
| Teva Pharmaceuticals USA, Inc. | 7 | $130 |
| Collegium Pharmaceutical, Inc. | 6 | $100 |
| Neurocrine Biosciences, Inc. | 4 | $68 |
| Idorsia Pharmaceuticals US Inc | 4 | $66 |
| Johnson & Johnson | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| Tris Pharma Inc | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Indivior Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$103
How this compares
$3,482 in reported general payments places this provider in the 95th percentile of 49 child & adolescent psychiatry providers in Wisconsin.
See all child & adolescent psychiatry providers in Wisconsin →
Other child & adolescent psychiatry in Juneau
- Derek CarlsonGreen Bay$54K
- Jennifer Lahmannla Crosse$2K
- Cherie SgambatiMilwaukee$1K
- Kayla PopeWinnebago$1K
- Juan FernandezWausau$767
- Rathna MallelaJanesville$617
- Rosa KimMilwaukee$616
- Alexandra McMurrayMadison$537
- John KorgerOshkosh$485
- Chirag ShahBrookfield$476
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.